AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Tanaka, Y Koido, S Chen, DS Gendler, SJ Kufe, D Gong, JL
Citation: Y. Tanaka et al., Vaccination with allogeneic dendritic induces antitumor immunity in cells fused to carcinoma cells MUC1 transgenic mice, CLIN IMMUNO, 101(2), 2001, pp. 192-200

Authors: Gendler, SJ Mukherjee, P
Citation: Sj. Gendler et P. Mukherjee, Spontaneous adenocarcinoma mouse models for immunotherapy, TRENDS MO M, 7(10), 2001, pp. 471-475

Authors: Gendler, SJ
Citation: Sj. Gendler, MUC1, the renaissance molecule, J MAMMARY G, 6(3), 2001, pp. 339-353

Authors: Mukherjee, P Ginardi, AR Tinder, TL Sterner, CJ Gendler, SJ
Citation: P. Mukherjee et al., MUC1-specific cytotoxic T lymphocytes eradicate tumors when adoptively transferred in vivo, CLIN CANC R, 7(3), 2001, pp. 848S-855S

Authors: Morikane, K Tempero, RM Sivinski, CL Kitajima, S Gendler, SJ Hollingsworth, MA
Citation: K. Morikane et al., Influence of organ site and tumor cell type on MUC1-specific tumor immunity, INT IMMUNOL, 13(2), 2001, pp. 233-240

Authors: Schroeder, JA Thompson, MC Gardner, MM Gendler, SJ
Citation: Ja. Schroeder et al., Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation ill the mouse mammarygland, J BIOL CHEM, 276(16), 2001, pp. 13057-13064

Authors: Mukherjee, P Ginardi, AR Madsen, CS Sterner, CJ Adriance, MC Tevethia, MJ Gendler, SJ
Citation: P. Mukherjee et al., Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred, J IMMUNOL, 165(6), 2000, pp. 3451-3460

Authors: Gong, J Apostolopoulos, V Chen, D Chen, H Koido, S Gendler, SJ McKenzie, IF Kufe, D
Citation: J. Gong et al., Selection and characterization of MUC1-specific CD8(+) T cells from MUC1 transgenic mice immunized with dendritic-carcinoma fusion cells, IMMUNOLOGY, 101(3), 2000, pp. 316-324

Authors: Klein, IK Ritland, SR Burgart, LJ Ziesmer, SC Roche, PC Gendler, SJ Karnes, WE
Citation: Ik. Klein et al., Adenoma-specific alterations of protein kinase C isozyme expression in Apc(MIN) mice, CANCER RES, 60(8), 2000, pp. 2077-2080

Authors: Ritland, SR Gendler, SJ Burgart, LJ Fry, DW Nelson, JM Bridges, AJ Andress, L Karnes, WE
Citation: Sr. Ritland et al., Inhibition of epidermal growth factor receptor tyrosine kinase fails to suppress adenoma formation in Apc(Min) mice but induces duodenal injury, CANCER RES, 60(17), 2000, pp. 4678-4681

Authors: Ritland, SR Leighton, JA Hirsch, RE Morrow, JD Weaver, AL Gendler, SJ
Citation: Sr. Ritland et al., Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: Lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse, CLIN CANC R, 5(4), 1999, pp. 855-863

Authors: Kardon, R Price, RE Julian, J Lagow, E Tseng, SCG Gendler, SJ Carson, DD
Citation: R. Kardon et al., Bacterial conjunctivitis in Muc1 null mice, INV OPHTH V, 40(7), 1999, pp. 1328-1335

Authors: Ritland, SR Gendler, SJ
Citation: Sr. Ritland et Sj. Gendler, Chemoprevention of intestinal adenomas in the Apc(Min) mouse by piroxicam:kinetics, strain effects and resistance to chemosuppression, CARCINOGENE, 20(1), 1999, pp. 51-58

Authors: Tempero, RM Rowse, GJ Gendler, SJ Hollingsworth, MA
Citation: Rm. Tempero et al., Passively transferred anti-MUC1 antibodies cause neither autoimmune disorders nor immunity against transplanted tumors in MUC1 transgenic mice, INT J CANC, 80(4), 1999, pp. 595-599
Risultati: 1-14 |